Rachel K. Hoyles

A multicenter, prospective, randomized, double‐blind, placebo‐controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma

Rachel K. Hoyles, R Ellis, Jessica Wellsbury et al. · Arthritis & Rheumatism · 2006 · 738 citations

Medicine, Pharmacology, Pharmacotherapy +13

Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

Nicole Goh, Rachel K. Hoyles, Christopher P. Denton et al. · Arthritis & Rheumatology · 2017 · 351 citations

Medicine, Clinical Sciences, Internal Medicine +17

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

Toby M. Maher, Veronica A Tudor, Peter Saunders et al. · The Lancet Respiratory Medicine · 2022 · 271 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +10

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study

Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 239 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK‐dependent transcriptional activation of type I collagen

Markella Ponticos, Alan Holmes, Shiwen Xu et al. · Arthritis & Rheumatism · 2009 · 220 citations

Life Sciences, Pathobiology, Pathology +17